Reaction
Metastases To Stomach reporting signals
As of the last recalculation, Metastases To Stomach appears in 380 FAERS reports alongside 14 co-occurring drug terms. The strongest observed disproportionality signal is DABRAFENIB (PRR 51.9).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Dabrafenib | 19 | 51.9 | 52.0 |
| Trametinib | 19 | 45.3 | 45.3 |
| Goserelin | 10 | 41.9 | 41.9 |
| Letrozole | 40 | 39.6 | 39.7 |
| Fulvestrant | 22 | 38.7 | 38.7 |
| Letrozole Tablets | 31 | 38.3 | 38.4 |
| Ribociclib | 20 | 36.6 | 36.6 |
| Lanreotide Acetate | 4 | 28.2 | 28.2 |
| Erlotinib | 4 | 22.8 | 22.9 |
| Erlotinib Hydrochloride | 5 | 22.2 | 22.2 |
| Pazopanib Hydrochloride | 8 | 16.5 | 16.5 |
| Olaparib | 6 | 15.9 | 15.9 |
| Cabozantinib | 12 | 14.1 | 14.1 |
| Durvalumab | 5 | 13.6 | 13.6 |